CRSP
$49.25-4.41%
CRISPR Therapeutics AG total returns by year (including dividends)
As of market close, Oct 16, 2026
CRISPR Therapeutics AG total returns by year (2017–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $52.44 | $49.25 | 0.0% | -6.1% | |
| 2025 | $39.36 | $52.44 | 0.0% | +33.2% | |
| 2024 | $62.60 | $39.36 | 0.0% | -37.1% | |
| 2023 | $40.65 | $62.60 | 0.0% | +54.0% | |
| 2022 | $75.78 | $40.65 | 0.0% | -46.4% | |
| 2021 | $153.11 | $75.78 | 0.0% | -50.5% | |
| 2020 | $60.91 | $153.11 | 0.0% | +151.4% | |
| 2019 | $28.57 | $60.91 | 0.0% | +113.2% | |
| 2018 | $23.48 | $28.57 | 0.0% | +21.7% | |
| 2017 | $20.26 | $23.48 | 0.0% | +15.9% |
- Annualized
- +10.5%
- 2017–2026
- Average year
- +28.4%
- 9 full years
- Best year
- +151.4%
- 2020
- Worst year
- -50.5%
- 2021
- Positive years
- 6/9
- 67% up
Annualized (CAGR)
+10.5%
2017–2026
Average year
+28.4%
9 full years
Best year
+151.4%
2020
Worst year
-50.5%
2021
Positive years
6/9
67% up
Total return by period#
Annual
-150%-100%-50%0%50%100%150%
2017+16%'17
2018+22%'18
2019+113%'19
2020+151%'20
2021-51%'21
2022-46%'22
2023+54%'23
2024-37%'24
2025+33%'25
2026-6.1%'26
Methodology#
Total returns, dividends reinvested, measured on CRSP. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is CRISPR Therapeutics AG's average annual return?
- Since 2017, CRISPR Therapeutics AG (CRSP) has returned about 10.5% a year (the compound annual growth rate) and an average calendar-year return of 28.4%.
- What were CRISPR Therapeutics AG's best and worst years?
- Over 2017–2026, the best year was 2020 (+151.4%) and the worst was 2021 (-50.5%).
- How often is CRISPR Therapeutics AG up in a year?
- 6 of the 9 full years since 2017 were positive — about 67% of the time.
More on CRISPR Therapeutics AG
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100